Robert Wills, DO
Pulmonary Disease · Henderson, NVNPI 1912369372
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,540 of the $8,310 with a category attached, or 66.7%. Intuitive Surgical accounts for 86.1% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $6,571, more than ten times the $213 reported in 2019.
Across 35 payments — averaging $237.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Merit Medical Systems Inc$245
- AstraZeneca$145
- Bayer$139
- Pulmonx Corporation$132
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$118
- plus $378 from 12 others
What the payments were for
- Travel & lodging$7769%
- Food & beverage$1,99424%
- Education$5,54067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $7,153 |
| Merit Medical Systems Inc | 2 | $245 |
| AstraZeneca | 2 | $145 |
| Bayer | 2 | $139 |
| Pulmonx Corporation | 1 | $132 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $118 |
| Veran Medical Technologies, Inc. | 1 | $116 |
| Olympus America Inc. | 1 | $61 |
| Astellas Pharma US Inc | 1 | $40 |
| Insmed, Inc. | 1 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $27 |
| GSK | 1 | $19 |
| Sanofi | 1 | $18 |
| Mylan Specialty L.p. | 1 | $16 |
| Boston Scientific | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
| Merck | 1 | $11 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,310 in reported general payments places this provider in the 75th percentile of 84 pulmonary disease providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Henderson
- Cyriac ChemplavilHenderson$18K
- Thomson ChemplavilHenderson$17K
- Sapna BhatiaHenderson$10K
- Rajiv AmesurHenderson$9K
- Syed AkbarullahHenderson$4K
- Michelle DanielianHenderson$2K
- Xenia SchneiderHenderson$805
- Hrishikesh KulkarniHenderson$606
- Kenneth MooneyHenderson$500
- James HsuHenderson$461
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.